Heterogeneity in cardiac amyloidosis care across Europe: a key opinion leader survey
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a form of cardiac amyloidosis characterized by misfolding and subsequent depositions of transthyretin (TTR) in the heart, leading to heart failure. ATTR-CM has recently become a treatable condition with the introduction of disease-modifying therapies (DMT) such as...